Mostrando 2 resultados de: 2
Everolimus-eluting stents in patients with bare-metal and drug-eluting in-stent restenosis
ArticleAbstract: Background - Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR) is more cPalabras claves:Angiography, drug-eluting stents, EVEROLIMUS, METAL, regression analysis, RestenosisAutores:Alberto Cárdenas, Alfonso F., Bastante T., Bethencourt A., Cequier A., Domínguez A., Fernández C., García del Blanco B., García-Touchard A., Gonzalo N., Jimenez-Quevedo P., López-Minguez J.R., Mainar V., Marti V., Masotti M., Melgares R., Moreno R., Moreu J., Otaegui I., Pérez-Vizcayno M.J., Sanchís J., Zueco J.Fuentes:scopusLong-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial
ArticleAbstract: Objectives The aim of this study was to compare the long-term efficacy of everolimus-eluting stentsPalabras claves:drug-eluting balloon(s), drug-eluting stent(s), everolimus-eluting stent(s), in-stent restenosisAutores:Alberto Cárdenas, Alfonso F., Bethencourt A., Cuesta J., Fernández C., García del Blanco B., García-Touchard A., Gonzalo N., Jimenez-Quevedo P., Lázaro-García R., Masotti M., Moreu J., Otaegui I., Pérez-Vizcayno M.J., Rivero F., Sanchís J., Veláquez M., Zueco J.Fuentes:scopus